Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Phosphodiesterase 4 inhibitors are a new class of oral medicines for treating chronic obstructive pulmonary disease, and the first Cochrane Review was published in May 2011. Jimmy Chong (left), Phillippa Poole (right) and Bonnie Leung from New Zealand, have updated this in November 2013. Jimmy summarises the latest evidence in this podcast.

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
library
Updated on: November 11, 2013, 9:09

Comments for improvement or correction are welcome.
Email: techsupport@cochrane.org